Epithelium-on Cross-linking Versus Observation of Fellow Eyes of Patients With Unilateral Clinically Evident Keratoconus
Launched by ASSIUT UNIVERSITY · Feb 19, 2024
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Keratoconus (KC) is a bilateral asymmetric progressive corneal degenerative disease associated with corneal thinning and protrusion with resultant irregular astigmatism and visual loss.
Although several studies showed that epithelium-off corneal cross-linking (epi-off CXL) is more effective in preventing KC progression compared with epithelium-on corneal cross-linking (epi-on CXL), the removal of corneal epithelium in epi-off CXL might be associated with a number of serious complications such as persistent epithelial defects and sight-threatening infectious keratitis. Additionally, recent ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients aged 12 to 30 years presented with forme fruste (FFKC) or subclinical KC, based on the following criteria:
- • 1. Normal slit lamp examination
- • 2. Normal topography in FFKC and suspicious topography in subclinical KC with asymmetric bow-tie or inferior steeping (inferior-superior value less than 1.40 D in the anterior sagittal curvature map in pentacam)
- • 3. Clinical and topographic features of KC in the other eye.
- Exclusion Criteria:
- • 1. Corrected distance visual acuity (CDVA) worse than 0.1 logMAR
- • 2. Corneal thickness at the thinnest location less than 400 μm
- • 3. Severe ocular allergy (active catarrhal keratoconjunctivitis)
- • 4. Other corneal or ocular diseases
- • 5. Systemic diseases such as diabetes mellitus and autoimmune diseases
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Trial Officials
Mahmoud Abdel-Radi, MD
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported